Top Clinical Trials companies in Poland by Cash and Short-Term Investments

This ranking features the top 5 Clinical Trials companies in Poland ranked by Cash and Short-Term Investments, totaling a Cash and Short-Term Investments of USD 111.23 M, for February 08, 2025.
#
Name
Cash and Short-Term Investments
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 59.26 M
Dec. 31, 2023 USD 6.78 -1.52%

Poland

2
USD 19.20 M
Dec. 31, 2023 USD 12.77 1.67%

Poland

3
USD 16.72 M
Dec. 31, 2023 USD 9.53 -0.94%

Poland

4
USD 13.43 M
Dec. 31, 2023 USD 10.78 -0.36%

Poland

5
USD 2.62 M
Dec. 31, 2023 USD 1.88 0.22%

Poland

Frequently Asked Questions
  • Which Clinical Trials company in Poland has the highest Cash and Short-Term Investments ?

    The Clinical Trials company in Poland with the highest Cash and Short-Term Investments is Ryvu Therapeutics S.A. (Warsaw Stock Exchange: RVU.WA) at USD 59.26 M.

  • Which Clinical Trials company in Poland has the lowest Cash and Short-Term Investments ?

    The Clinical Trials company in Poland with the lowest Cash and Short-Term Investments is Medinice S.A. (Warsaw Stock Exchange: ICE.WA) at USD 2.62 M.

SV Wall Street